| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Mouse Genomics Lab,* Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom; the Department of Orthopaedics, Brown Medical School/Rhode Island Hospital, Providence, Rhode Island; and the Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
Mutations in the gene encoding matrilin-3 (MATN3), a noncollagenous extracellular matrix protein, have been reported in a variety of skeletal diseases, including multiple epiphyseal dysplasia, which is characterized by irregular ossification of the epiphyses and early-onset osteoarthritis, spondylo-epimetaphyseal dysplasia, and idiopathic hand osteoarthritis. To assess the role of matrilin-3 in the pathogenesis of these diseases, we generated Matn3 functional knockout mice using embryonic stem cell technology. In the embryonic growth plate of the developing long bones, Matn3 null chondrocytes prematurely became prehypertrophic and hypertrophic, forming an expanded zone of hypertrophy. This expansion was attenuated during the perinatal period, and Matn3 homozygous null mice were viable and showed no gross skeletal malformations at birth. However, by 18 weeks of age, Matn3 null mice had a significantly higher total body bone mineral density than Matn1 null mice or wild-type littermates. Aged Matn3 null mice were much more predisposed to develop severe osteoarthritis than their wild-type littermates. Here, we show that matrilin-3 plays a role in modulating chondrocyte differentiation during embryonic development, in controlling bone mineral density in adulthood, and in preventing osteoarthritis during aging. The lack of Matn3 does not lead to postnatal chondrodysplasia but accounts for higher incidence of osteoarthritis.
This article has been cited by other articles:
 |
|
 |
|
  D. Mariappan, J. Winkler, S. Chen, H. Schulz, J. Hescheler, and A. Sachinidis Transcriptional profiling of CD31(+) cells isolated from murine embryonic stem cells. Genes Cells, February 1, 2009; 14(2): 243 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Posey, K. Hankenson, A. C. Veerisetty, P. Bornstein, J. Lawler, and J. T. Hecht Skeletal Abnormalities in Mice Lacking Extracellular Matrix Proteins, Thrombospondin-1, Thrombospondin-3, Thrombospondin-5, and Type IX Collagen Am. J. Pathol., June 1, 2008; 172(6): 1664 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nicolae, Y.-P. Ko, N. Miosge, A. Niehoff, D. Studer, L. Enggist, E. B. Hunziker, M. Paulsson, R. Wagener, and A. Aszodi Abnormal Collagen Fibrils in Cartilage of Matrilin-1/Matrilin-3-deficient Mice J. Biol. Chem., July 27, 2007; 282(30): 22163 - 22175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Leighton, S. Nundlall, T. Starborg, R. S. Meadows, F. Suleman, L. Knowles, R. Wagener, D. J. Thornton, K. E. Kadler, R. P. Boot-Handford, et al. Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation Hum. Mol. Genet., July 15, 2007; 16(14): 1728 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hills, R. Mazzarella, K. Fok, M. Liu, O. Nemirovskiy, J. Leone, M. D. Zack, E. C. Arner, M. Viswanathan, A. Abujoub, et al. Identification of an ADAMTS-4 Cleavage Motif Using Phage Display Leads to the Development of Fluorogenic Peptide Substrates and Reveals Matrilin-3 as a Novel Substrate J. Biol. Chem., April 13, 2007; 282(15): 11101 - 11109. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
